玻璃酸钠治疗Ⅱ～Ⅲ阶段颞下颌关节紊乱综合症的疗效分析  

Sodium Hyaluronate Treatment Phase Ⅱ～Ⅲ Temporomandibular Joint Disorder Syndrome Curative Effect Analysis

作　　者：赵文[1] 叶蕾[1] 李慧琴[1] 

机构地区：[1]陕西省榆林市第一医院,陕西榆林718000

出　　处：《科技创新导报》2014年第34期242-242,共1页Science and Technology Innovation Herald

摘　　要：目的研究玻璃酸钠、2%利多卡因注射液在治疗27例II^III阶段颞下颌关节紊乱综合症的临床效果分析;方法把27例患者任意分为22例实验组和5例对照组,前者采用玻璃酸钠1 m L(10 mg)、2%利多卡因0.5 m L行患侧关节上腔注射,后者用2%利多卡因1 m L、维生素B12500单位行关节上腔注射。结果治疗组有效率90.90%,对照组有效率40.00%,两组实验有明显差异。结果玻璃酸钠在治疗II^III阶段颞下颌关节紊乱综合症中效果显著。Study of sodium hyaluronate,2% lidocaine injection in the treatment of the clinical effect of 27 cases of Ⅱ～Ⅲstage temporomandibular joint disorder syndrome analysis;specific methods：the 27 patients were arbitrarily divided into 22 cases of the experimental group and 5 cases in the control group,the former using 1ml sodium hyaluronate（10mg）,2% lidocaine 0.5ml patients the injection side articular cavity,the latter with injection of 2% lidocaine 1ml,vitamin B12500 unit for articular cavity.Results：the effective rate of treatment group 95.45%,control group with an efficiency of 40%,two groups have obvious difference.Results：the effect of sodium hyaluronate in the treatment of Ⅱ～Ⅲ stage of temporomandibular joint disturbance syndrome significantly.

关 键 词：玻璃酸钠2%利多卡因注射液 关节上腔注射 颞下颌紊乱综合症 

分 类 号：S858.283.2[农业科学—临床兽医学]